PCSA stock

Processa Pharmaceuticals Inc (PCSA) financials · $5.9M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Processa Pharmaceuticals Inc (PCSA) $5.9M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$14.0M-$12.1M
Net Income-$13.6M-$11.9M
EPS (Diluted)-$10.36-$3.87
Cached annual balance sheet
LineFY2025FY2024
Total Assets$7.81M$3.23M
Current Assets$5.67M$1.87M
Cash & Equivalents$5.54M$1.19M
PP&E$3.81K$5.02K
Total Liabilities$2.24M$1.53M
Current Liabilities$2.24M$1.53M
Shareholders' Equity$5.58M$1.70M
Retained Earnings-$100.8M-$87.2M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$11.4M-$11.2M
CapExN/A$3.24K
Investing Cash Flow-$850.0K-$3.24K
Financing Cash Flow$16.6M$7.73M
Net Change in Cash$4.35M-$3.51M
Free Cash FlowN/A-$11.2M
These statements as JSON? API free 100/day

FAQ

What is PCSA P/E and revenue?

Processa Pharmaceuticals Inc (PCSA) $5.9M cap.

What is PCSA revenue?

PCSA income-statement cache has no revenue figure yet.

Is PCSA profitable?

Processa Pharmaceuticals Inc last cached net income is -$13.6M (FY2025).

What are PCSA total assets?

Processa Pharmaceuticals Inc last cached total assets are $7.81M (FY2025).

What is PCSA free cash flow?

No cached cash-flow row for PCSA yet.

Not investment advice. Cached statements, not a live tape.